Evidence map›Paper›PMID 28243722›Full record

Trial reportStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2017

Radiotherapy of painful heel spur with two fractionation regimens : Results of a randomized multicenter trial after 48 weeks' follow-up.

Benjamin Prokein, Henrik Holtmann, Matthias G Hautmann, Hans-Peter Rösler, Stefan Graeber, Yvonne Dzierma, Christian Ruebe, Jochen Fleckenstein, Marcus Niewald

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Implementing a low-dose radiation therapy program for musculoskeletal pain disorders: tips, tricks, and essentials for clinical researchers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  4. Article
  5. Long-term effect and prognostic factors of a low-dose radiotherapy of painful plantar calcaneal spurs : A retrospective unicenter study.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2021
    Article
  6. Radiotherapy for osteoarthritis-an analysis of 295 joints treated with a linear accelerator.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020
    Article
  7. Radiotherapy for osteoarthritis of the ankle and tarsal joints-analysis of 66 joints.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2020
    Article
  8. Re-irradiation for osteoarthritis-retrospective analysis of 217 joints.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2019
    Article
  9. Efficacy of Radiotherapy.Deutsches Arzteblatt international · 2019
    Article
  10. Low-dose radiotherapy: Mayday, mayday. We've been hit!Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2019
    Article
  11. Radiotherapy of epicondylitis humeri : Analysis of 138 elbows treated with a linear accelerator.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2019
    Article
  12. Is low dose radiotherapy an effective treatment for Baker's cyst?Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Benjamin ProkeinDepartment of Radiotherapy and Radiooncology, Saarland University Hospital, Kirrberger Str. 1, 66421, Homburg, Germany.
Henrik HoltmannDepartment of Radiotherapy and Radiooncology, Saarland University Hospital, Kirrberger Str. 1, 66421, Homburg, Germany.
Matthias G HautmannDepartment of Radiotherapy, University Hospital of Regensburg, Franz-Josef-Strauß-Allee 1, 93053, Regensburg, Germany.
Hans-Peter RöslerDepartment of Radiooncology and Radiotherapy, University Hospital of Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
Stefan GraeberInstitute of Medical Biometrics, Epidemiology and Medical Informatics, Saarland University Hospital, Kirrberger Str.1, 66421, Homburg, Germany.
Yvonne DziermaDepartment of Radiotherapy and Radiooncology, Saarland University Hospital, Kirrberger Str. 1, 66421, Homburg, Germany.
Christian RuebeDepartment of Radiotherapy and Radiooncology, Saarland University Hospital, Kirrberger Str. 1, 66421, Homburg, Germany.
Jochen FleckensteinDepartment of Radiotherapy and Radiooncology, Saarland University Hospital, Kirrberger Str. 1, 66421, Homburg, Germany.
Marcus NiewaldDepartment of Radiotherapy and Radiooncology, Saarland University Hospital, Kirrberger Str. 1, 66421, Homburg, Germany. marcus.niewald@uks.eu.ORCID http://orcid.org/0000-0001-6266-0993
Saarland University · DEDüsseldorf University Hospital · DEJohannes Gutenberg University Mainz · DEUniversity Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn this randomized multicenter trial, we compared the effect of a lower single dose of 0.5 Gy vs. a standard single dose of 1 Gy concerning pain relief and quality of life, while maintaining a uniform total dose of 6 Gy. On the basis of laboratory observations, the lower single dose would be expected to be more effective. PATIENTS AND

methodsA total of 127 patients suffering from painful heel spur were randomized: Patients in the standard group were treated with single fractions of 6 × 1 Gy twice a week, while the experimental group was treated with single fractions of 12 × 0.5 Gy three times a week. Patients who did not show satisfactory pain relief after 12 weeks were offered re-irradiation with the standard dose. The study's primary endpoints were pain relief and quality of life. Therapy results were evaluated and compared based on follow-up examinations after 12 and 48 weeks.

resultsThe data of 117 patients could be evaluated. There was no significant difference between the groups concerning the results of a visual analogue scale (VAS), Calcaneodynia Score (CS), and the somatic scale of the 12-Item Short-Form Health Survey(SF-12). Patients undergoing re-irradiation showed a significant benefit concerning pain relief. Their total outcome was comparable to patients showing a good response from the beginning. No relevant acute or chronic side effects were recorded.

conclusionBoth patient groups showed good results concerning pain relief. A fractionation schedule of 12 × 0.5 Gy was not superior to the current standard dose of 6 × 1 Gy. Further trials are necessary to explore the best fractionation schedule.

Indexed as

Dose Fractionation, RadiationAdultFemaleFollow-Up StudiesHeel SpurHumansMaleMiddle AgedPainPain MeasurementParticle AcceleratorsQuality of LifeRadiotherapy DosageAnalgesiaCalcaneal spurPainQuality of lifeRadiotherapy

Identifiers

PMID28243722
OpenAlexW2594586874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.